{"address1": "2929 North Commerce Parkway", "city": "Miramar", "state": "FL", "zip": "33025", "country": "United States", "phone": "954 842 2024", "fax": "954 842 2037", "website": "https://www.hcwbiologics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases in the United States. The company's lead products include HCW9218, which is in Phase 1 clinical chemo-refractory/chemo-resistant solid tumors with pancreatic, ovarian, breast, prostate, and colorectal cancers, as well as Phase 2 clinical trial with metastatic advanced stage ovarian cancer patients; and HCW9302 for autoimmune and proinflammatory diseases, such as alopecia areata diseases. It also develops HCW9201, a cell-based therapy that is in Phase I clinical trials for the treatment of patients with relapsed/refractory acute myelogenous leukemia; and HCW9206, an injectable immunotherapeutic to use as adjuvant for adoptive cell therapy in cancer treatment. The company was incorporated in 2018 and is headquartered in Miramar, Florida.", "fullTimeEmployees": 45, "companyOfficers": [{"maxAge": 1, "name": "Dr. Hing C. Wong Ph.D.", "age": 69, "title": "Founder, CEO, Director & Secretary", "yearBorn": 1955, "fiscalYear": 2023, "totalPay": 425880, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Rebecca  Byam CPA, M.B.A.", "age": 67, "title": "Chief Financial Officer", "yearBorn": 1957, "fiscalYear": 2023, "totalPay": 300300, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Peter  Rhode Ph.D.", "age": 65, "title": "Chief Scientific Officer & VP of Clinical Operations", "yearBorn": 1959, "fiscalYear": 2023, "totalPay": 251160, "exercisedValue": 0, "unexercisedValue": 28247}, {"maxAge": 1, "name": "Ms. Nicole  Valdivieso Esq.", "title": "Vice President of Legal Affairs", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Lee D. Flowers", "age": 77, "title": "Senior Vice President of Business Development", "yearBorn": 1947, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.2821, "open": 0.28, "dayLow": 0.274, "dayHigh": 0.281, "regularMarketPreviousClose": 0.2821, "regularMarketOpen": 0.28, "regularMarketDayLow": 0.274, "regularMarketDayHigh": 0.281, "payoutRatio": 0.0, "beta": 0.715, "forwardPE": -0.5107273, "volume": 165011, "regularMarketVolume": 165011, "averageVolume": 6208335, "averageVolume10days": 99310, "averageDailyVolume10Day": 99310, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 12621989, "fiftyTwoWeekLow": 0.21, "fiftyTwoWeekHigh": 2.52, "priceToSalesTrailing12Months": 3.610419, "fiftyDayAverage": 0.35972, "twoHundredDayAverage": 0.496675, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 23278078, "profitMargins": 0.0, "floatShares": 22479578, "sharesOutstanding": 44545000, "sharesShort": 450173, "sharesShortPriorMonth": 835487, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0101, "heldPercentInsiders": 0.44412, "heldPercentInstitutions": 0.07024, "shortRatio": 2.49, "shortPercentOfFloat": 0.017, "impliedSharesOutstanding": 44934100, "bookValue": -0.264, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -37331072, "trailingEps": -0.77, "forwardEps": -0.55, "enterpriseToRevenue": 6.659, "enterpriseToEbitda": -0.659, "52WeekChange": -0.8307229, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 0.2809, "targetHighPrice": 3.0, "targetLowPrice": 3.0, "targetMeanPrice": 3.0, "targetMedianPrice": 3.0, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 998221, "totalCashPerShare": 0.026, "ebitda": -35338408, "totalDebt": 12929280, "quickRatio": 0.055, "currentRatio": 0.07, "totalRevenue": 3495990, "revenuePerShare": 0.094, "returnOnAssets": -0.71953005, "returnOnEquity": -5.37242, "grossProfits": -4116913, "freeCashflow": -4815605, "operatingCashflow": -15287339, "revenueGrowth": -0.5, "grossMargins": -1.17761, "ebitdaMargins": 0.0, "operatingMargins": -8.65393, "financialCurrency": "USD", "symbol": "HCWB", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1626787800000, "preMarketChange": -0.020900011, "preMarketChangePercent": -7.4403744, "shortName": "HCW Biologics Inc.", "longName": "HCW Biologics Inc.", "corporateActions": [], "preMarketTime": 1743595552, "regularMarketTime": 1743537602, "exchange": "NGM", "messageBoardId": "finmb_628452149", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -0.42537773, "regularMarketPrice": 0.2809, "cryptoTradeable": false, "marketState": "PRE", "preMarketPrice": 0.26, "regularMarketChange": -0.0011999905, "regularMarketDayRange": "0.274 - 0.281", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 6208335, "fiftyTwoWeekLowChange": 0.07090001, "fiftyTwoWeekLowChangePercent": 0.3376191, "fiftyTwoWeekRange": "0.21 - 2.52", "fiftyTwoWeekHighChange": -2.2391, "fiftyTwoWeekHighChangePercent": -0.88853174, "fiftyTwoWeekChangePercent": -83.072296, "epsTrailingTwelveMonths": -0.77, "epsForward": -0.55, "fiftyDayAverageChange": -0.07881999, "fiftyDayAverageChangePercent": -0.21911484, "twoHundredDayAverageChange": -0.21577501, "twoHundredDayAverageChangePercent": -0.43443903, "priceToBook": -1.0640152, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-07-20", "displayName": "HCW Biologics", "trailingPegRatio": null}